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Abstract
Background: Chronic active EBV infection (CAEBV) of T-cell or NK-cell type is an EBV+ polyclonal,
oligoclonal or often monoclonal lymphoproliferative disorder (LPD) recognized as representing
the spectrum of EBV-associated T-cell and NK-cell LPD with different clinical presentations;
one systemic and two cutaneous disorders including hydroa vacciniforme-like T-cell LPD and
mosquito bite hypersensitivity. The systemic form of the disease is characterized by fever,
persistent hepatitis, hepatosplenomegaly and lymphadenopathy, which shows varying degrees
of clinical severity depending on the immune response of the host and the EBV viral load.
Case reports: We described the clinicopathological ﬁndings of two children with CAEBV with a
brief review of the literature.
Conclusions: Recognition of the disease is important for adequate management of the patient.
EBV analysis should be included in the principal diagnostic tests for febrile children.
© 2015 Hospital Infantil de México Federico Gómez. Published by Masson Doyma México S.A.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
PALABRAS CLAVE
Virus de Epstein-Barr;
Nin˜os;
Infección crónica
Infección crónica activa por virus de Epstein-Barr: experiencia del Centro Médico
Samsung en Corea del Sur
Resumen
activa;
Linfocitosis de células
NK;
Introducción: La infección crónica activa (CA) de células T o células tipo NK por virus de
Epstein-Barr (VEB) es un desorden linfoproliferativo (DLP) VEB+ policlonal, oligoclonal o, fre-
cuentemente, monoclonal reconocido como representación del espectro del DLP de células
n VEB que tiene diversas presentaciones clínicas: un padecimiento
e incluyen el DLP de células T que semeja hidroa vacciniforme y la
ura de mosquito. Los síntomas de la enfermedad sistémica incluyenHipersensibilidad por
picadura de mosquito
T y células NK asociado co
sistémico y dos cutáneos qu
hipersensibilidad por picad∗ Corresponding author.
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ﬁebre,  hepatitis  persistente,  hepatoesplenomegalia  y  linfadenopatías  que  muestran  diferente
grado  de  severidad  clínica,  dependiendo  de  la  respuesta  inmune  del  hospedero  y de  la  carga
viral  del  VEB.
Casos clínicos:  Se  describen  los  hallazgos  clínico-patológicos  de  dos  nin˜os  con  CAVEB  y  una  breve
revisión de  la  literatura.
Conclusiones:  Es  importante  reconocer  esta  enfermedad  para  proporcionar  el  manejo  adecuado
al paciente.  El  análisis  de  VEB  debería  incluirse  como  una  de  las  principales  pruebas  diagnósticas
en  nin˜os  con  ﬁebre.
© 2015  Hospital  Infantil  de  México  Federico  Gómez.  Publicado  por  Masson  Doyma  México  S.A.
Este  es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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symptoms and  signs  since  he  was  5  years  old.  Birth  weight1. Introduction
Chronic  active  Epstein-Barr  virus  infection  (CAEBV)  is  a  clin-
ical term  initially  deﬁned  by  Straus  as  a  disease  related
to chronic  or  persistent  infection  of  EBV.  Suggested  crite-
ria for  diagnosing  severe  chronic  EBV  infection  includes
the following:  1)  severe  illness  of  >6  months  duration  that
began as  primary  EBV  infection  and  is  associated  with  grossly
abnormal EBV  antibody  titers  [IgG  to  viral  capsid  antigen
(VCA) =  ∼1:5120;  antibody  to  early  antigen  (EA)  =  ∼1:640;
or antibody  to  EBV  nuclear  antigen  (EBNA)  <2],  and  2)
histological evidence  of  major  organ  involvement  such  as
interstitial pneumonia,  hypoplasia  of  some  bone  marrow
elements, uveitis,  lymphadenitis,  persistent  hepatitis  or
splenomegaly, and  3)  detection  of  increased  quantities  of
EBV in  affected  tissues  by  anticomplementary  immuno-
ﬂuorescence for  EBNA  or  nucleic  acid  hybridization1.  In
early reports,  the  cellular  lineage  of  EBV-infected  cells
has not  drawn  attention;  however,  subsequent  reports  doc-
umented that  EBV  mainly  exists  in  T-cells2,3 but  not  in
B-cells, as  revealed  by  dual  staining  immunoﬂuorescence
analysis3.  Just  as  the  accumulation  of  clinical  and  labora-
tory data  for  CAEBV,  it  has  been  recognized  that  clinical
and laboratory  ﬁndings  of  CAEBV  are  of  a  broader  spec-
trum than  initially  thought.  Because  individual  cases  do  not
fulﬁll  the  diagnostic  criteria  initially  proposed,  Kimura  and
colleagues modiﬁed  the  diagnostic  criteria  for  CAEBV  as  fol-
lows:  (1)  illness  ≥3  months  duration  [EBV-related  illness
or symptoms  including  fever,  persistent  hepatitis,  exten-
sive lymphadenopathy,  hepatosplenomegaly,  pancytopenia,
uveitis, interstitial  pneumonia,  hydroa  vacciniforme  (HV),
and  hypersensitivity  to  mosquito  bites  (HMB)];  (2)  increased
amounts of  EBV  DNA  or  grossly  abnormal  levels  of  EBV
antibodies, for  instance,  detection  of  EBV  DNA  in  tissues
or peripheral  blood  by  Southern  blot  hybridization;  EBV-
encoded small  RNA-1-positive  cells  in  affected  tissues  or
peripheral blood,  >102.5 copies  of  EBV  DNA/g  of  DNA  of
peripheral blood  mononuclear  cells;  and  grossly  abnormal
levels of  EBV  antibodies  (anti-VCA  IgG  titers  ≥5120  or  anti-
EA IgG  titers  ≥640),  and  (3)  no  evidence  of  previous  immuno-
logical abnormalities  or  other  recent  infection  that  might
explain the  observed  condition.4
Based  on  the  accumulated  data,  CAEBV  of  T-cell  or
NK-cell type  has  been  recently  deﬁned  as  a  systemic
EBV+ polyclonal,  oligoclonal  or  often  monoclonal  lym-
phoproliferative disorder  (LPD)  characterized  by  fever,
w
v
oersistent  hepatitis,  hepatosplenomegaly  and  lymphadeno-
athy, which  shows  varying  degrees  of  clinical  severity
epending on  the  immune  response  of  the  host  and  the  EBV
iral load.5,6
CAEBV  is  often  accompanied  by  cutaneous  lesions  such
s severe  mosquito  bite  allergy  and  hydroa-vacciniforme
HV)-like T-cell  lymphoproliferative  disease.  Mosquito  bite
ypersensitivity (or  mosquito  bite  allergy,  MBH)  is  a  unique
utaneous manifestation  of  CAEBV  infection  characterized
y abnormally  intense  local  reaction  at  arthropod  bite  area
ssociated with  systemic  symptoms  and  signs  like  fever,  lym-
hadenopathy and  liver  dysfunction.  EBV  genome  is  mainly
ound within  NK  cells  of  peripheral  blood  of  MBH  patients
ho often  show  NK  cell  lymphocytosis.7--10
HV-like  LPD  is  an  EBV-associated  polyclonal,  oligoclonal,
r monoclonal  cutaneous  T-cell  lymphoproliferative  dis-
ase characterized  by  recurrent  vesiculopapular  eruptions,
ainly on  the  face  and  arms.  It  shows  a  broad  spec-
rum of  clinical  aggressiveness  and  usually  a  long  clinical
ourse with  risk  to  develop  systemic  lymphoma.  As  the
isease progresses  patients  develop  severe  and  extensive
kin lesions  with  systemic  symptoms  including  fever,  hep-
tosplenomegaly and  lymphadenopathy.  Classic  HV,  severe
V and  HV-like  T-cell  lymphoma  constitute  a continuum
pectrum of  EBV-associated  HV-like  LPD.5,11--14
Recently,  the  three  disorders  indicated  above  have  been
ecognized as  representing  the  spectrum  of  EBV-associated
-cell and  NK-cell  LPD  with  different  clinical  presentations;
ne systemic  and  two  cutaneous  disorders  including  HV-like
-cell LPD  and  MBH.14
.  Case reports
he  patients  described  in  the  following  two  case  reports
epict typical  clinical  manifestations  of  CAEBV  with  MBH  in
hildren. Case  2  was  reported  previously.15
.1.  Case  1
 15-year-old  Korean  boy  was  admitted  to  the  hospital  with
hronic intermittent  dermatological  and  various  systemicas normal  and  adequate  for  gestational  age.  At  a  recent
isit to  a  pediatric  department,  he  showed  adequate  height
f 163.7  cm  for  his  age,  but  a  low  body  weight  of  39.6  kg.
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pigure  1  Case  1.  (A)  Mosquito  bite  hypersensitivity  at  12  yea
f  age.  (C)  Similar  skin  lesion  in  the  neck.
At  5  years  old,  fever,  cough,  and  abdominal  disten-
ion suddenly  developed.  White  blood  cell  count  was
2.1 ×  103/l  (lymphocytes  70%,  segmented  neutrophils
1%, eosinophils  1%,  and  monocytes  8%).  Qualitative  ﬂu-
rescent antinuclear  antibody  was  negative.  Following  a
linical diagnosis  of  intestinal  perforation,  he  underwent  a
ubtotal colectomy  and  ileostomy.  One  month  after  surgery,
ymphocyte subset  counts  by  ﬂow  cytometry  showed  low
umbers of  B-  and  T-cells,  with  markedly  increased  NK-cells
CD16 +  CD56+  =  68%,  normal  range  5.6-31%);  1,579/l  (nor-
al range  100-430/l).
He  was  subsequently  hospitalized  ﬁve  times  in  3  years
ecause of  acute  pharyngotonsillitis,  upper  respiratory
nfection, bronchiolitis,  and  pneumonia  and  experienced
ecurrent fever  two  or  three  times  per  month.  At  10  years
ld, he  was  hospitalized  because  of  upper  respiratory  tract
nfection. Splenomegaly  of  10.76  cm  was  found  inciden-
ally during  workup.  From  the  age  of  10,  intense  skin
esponses manifested  at  mosquito-  or  other  bug-bitten  sites
hat were  characterized  by  an  initial  bullous  change  fol-
owed by  ulceration,  crust  formation,  and  scarring  with
igmentation (Fig.  1).  Most  lesions  were  <1  cm  in  diameter
nd were  frequently  accompanied  by  fever.  Such  cutaneous
esions tended  to  occur  in  the  summer  and  on  the  upper
nd lower  extremities.  Laboratory  tests  performed  at  the
ime of  severe  mosquito  bite  allergy  showed  mild  elevation
f aspartate  transaminase/alanine  transaminase  (AST/ALT)
ith signiﬁcant  elevation  of  alkaline  phosphatase  (200  U/l)
nd globin  (4.5  to  4.8  g/dl).
A skin  biopsy  obtained  from  a  lesion  was  reported  as
ndicating a  possibility  of  Sweet’s  syndrome.  Abdominal
onography indicated  splenomegaly.  Differential  counts  of
eripheral blood  showed  low  B-  and  T-cell  populations,  and
K-cell lymphocytosis  [CD16  +  CD56+  =  62%;  3520/l  (normal
ange =  70-1200/l)].  The  serum  IgE  level  was  increased  to
0,370 U/ml  although  no  speciﬁc  response  to  various  aller-
en stimuli  was  identiﬁed.  Despite  no  proven  family  history, clinical  impression  of  hyper-IgE  syndrome  was  made  as
he ﬁrst  differential  diagnosis.  A  genetic  study  that  included
TAT3 sequencing  was  performed  but  failed  to  ﬁnd  the
xpected mutation.  In  considering  the  clinical  course  and
r
(
g
bage.  (B)  Erythematous  scaly  skin  lesion  of  the  face  at  15  years
K  lymphocytosis,  CAEBV  or  EBV-associated  lymphoprolife-
ative disease  was  considered  as  other  differential  diagnoses
nd relevant  tests  were  established.
Serologic  tests  showed  positivity  of  EBV  VCA-IgG,  EBV-
arly antigen,  and  negativity  of  EBV  VCA  IgM.  Using  a  whole
lood sample,  real-time  quantitative  PCR  for  EBV  DNA  was
erformed to  determine  the  viral  load  in  blood  (11,450
opies/5 l of  whole  blood).  Subsequently,  he  underwent  a
egular checkup  of  viral  genome  copy  number,  which  was
ound to  be  consistently  high,  ranging  from  212.5  copies/l
o 1,562  copies/l  of  whole  blood.  His  skin  problem  associ-
ted with  mosquitoes  or  bugs  had  occurred  intermittently
ver since,  while  intermittent  episodes  of  febrile  illness
evoid of  skin  lesion  had  also  persisted.  Nonspeciﬁc  skin
roblem persisted  for  15  months.  Physical  examination
evealed erythematous  to  brownish  scaly  patches  with  yel-
owish crusts  on  his  face,  neck,  scalp,  upper  chest,  and  upper
ack. He  was  treated  with  topical  steroids  and  oral  anti-
istamines under  impression  of  seborrheic  dermatitis  for
1 months  (Fig.  1).  Two  months  prior  to  examination,  his
ymptoms became  aggravated  and  he  visited  a  dermatology
linic. Two  skin  biopsies  from  his  face  and  neck  were  taken
nd EBV  in  situ  hybridization  was  performed.  The  biopsies
howed increased  lymphoplasma  cells  in  the  superﬁcial  and
eep dermis  with  occasional  periadnexal  distribution.  There
as no  clear  atypia  in  most  lymphoid  cells.  Immunohisto-
hemistry showed  many  CD56+  lymphoid  cells.  There  were
umerous lymphocytes  showing  a  nuclear  positive  reaction
o EBER  in  situ  hybridization.  Retrospectively,  EBER  in  situ
ybridization was  applied  to  both  the  skin  biopsy  of  the
ower leg  taken  for  severe  mosquito  bite  allergy  and  that  of
he perforated  intestine  resected  10  years  ago  (Fig.  2).  Many
ymphoid cells  with  a  positive  reaction  were  identiﬁed,  not
nly  in  the  skin  but  also  in  the  intestinal  wall  and  sinusoids
f the  liver  and  lymph  node,  which  conﬁrmed  CAEBV  infec-
ion with  mosquito  bite  allergy  and  NK  lymphocytosis.  The
atient was  treated  conservatively.  Two  years  later  he  was
eadmitted because  of  hemophagocytic  lymphohistiocytosis
HLH). He  was  treated  according  to  the  HLH-2004  treatment
uideline16 and  responded  transiently,  but  later  developed
owel perforation  and  died  of  sepsis.
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Figure  2  Case  1.  (A)  Perforated  colon  at  5  years  of  age.  (B)  Microscopic  ﬁndings  show  acute  and  chronic  inﬂammation  with
granulation  tissue.  (C)  EBER  in  situ  hybridization  reveals  EBV-positive  lymphocytes.  (D)  EBV-positive  lymphocytes  are  positive  for
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2.2.  Case  2
A  10-year-old  Korean  boy  presented  to  the  Department
of Dermatology  complaining  of  intense  skin  reactions  at
mosquito bite  sites.  He  exhibited  multiple  scattered,
punctuated ulcerations  on  bilateral  lower  extremities.  In
addition to  the  marked  cutaneous  reaction,  he  also  endorsed
systemic symptoms  including  fever  following  insect  bites
throughout his  childhood.  A  skin  biopsy  was  taken  and  local
treatment for  the  lesion  was  administered  without  further
systemic evaluation.  At  16  years  of  age,  the  patient  admit-
ted with  a  palpable  mass  located  on  the  left  neck  of  2  3
weeks’ duration.  On  physical  examination,  a  conglomer-
ate of  large  lymph  nodes  was  present  in  the  left  neck,  the
largest of  which  measured  7  ×  5  cm.  Due  to  his  history  of
skin lesions,  careful  inspection  of  his  legs  was  performed,
revealing multiple  shallow  ulcers  with  healing  scars.  Com-
puted tomography  and  positron  emission  tomography  scan
showed multiple  poorly  enhancing  and  variable  sized  homo-
geneous lymph  nodes  involving  the  left  cervical  region  and
bilateral inguinal  areas.  In  addition,  there  were  multifo-
cal lesions  demonstrating  increased  2-deoxy-2-[ﬂuorine-18]
ﬂuoro-D-glucose  uptake  in  the  skin  and  subcutaneous  layer
of bilateral  cheeks  and  buttocks.  On  hematologic  exam-
ination, blood  cell  counts  and  lactic  acid  dehydrogenase
level were  within  normal  limits.  Anti-VCA  IgG,  anti-EA  and
anti-EBNA IgG  were  positive  and  anti-VCA  IgM  was  negative.
The EBV  DNA  copy  number  was  529.8  copies/l  of  whole
blood.
h
p
b
aLymph  node  biopsy  was  performed  revealing  widen-
ng of  the  paracortex  with  inﬁltration  of  heterogeneous
nﬂammatory cells  including  small  lymphocytes,  histiocytes
nd many  eosinophils.  The  inﬂammatory  inﬁltrate  was
unctuated by  scattered  large  mononuclear  or  multinuclear
eed-Sternberg (RS)-like  atypical  cells,  which  had  large
osinophilic nucleoli  and  thick  nuclear  membrane.  Using
mmunohistochemical study,  the  RS-like  cells  demonstrated
 strong  membranous  stain  for  CD30  and  perinuclear  staining
or CD15  and  were  positive  for  PAX-5  and  LMP-1,  but  negative
or CD20,  CD3,  and  EBNA-2.  Atypical  mononuclear  and  mult-
nuclear RS-like  cells  showed  a  positive  signal  by  EBER  in  situ
ybridization. Aside  from  the  RS-like  cells,  many  small  lym-
hocytes scattered  in  the  background  were  also  positive  for
BER in  situ  hybridization.  No  abnormal  ﬁndings  were  noted
n the  bone  marrow  biopsy  except  for  a  few  EBV-positive
mall lymphocytes.  The  skin  biopsy  from  the  region  of
osquito-bite allergy  in  2002  was  retrospectively  reviewed,
evealing severe  necrosis  of  the  epidermis  and  upper  dermis.
here was  inﬁltration  of  small  lymphocytes,  histiocytes  and
any eosinophils  around  the  blood  vessels  and  hair  follicles
nd the  blood  vessel  lumens  were  often  obliterated  by  red
lood cells  (RBCs)  and  ﬁbrin.  Immunohistochemical  analysis
evealed that  the  inﬁltrating  cells  were  heterogeneous  in
heir lineage;  some  were  positive  to  CD3  and  CD4  or  CD8
elper or  cytotoxic  T  cells,  whereas  others  were  NK  cells
ositive for  CD56.  Many  EBV-positive  cells  were  documented
y EBER  in  situ  hybridization.  The  diagnosis  of  chronic
ctive EBV  infection  with  mosquito  bite  hypersensitivity
14
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Table  1  Clinical  and  laboratory  ﬁndings  of  13  patients  with  chronic  active  EBV  infection  related  disease.
Patient  Age  at
admission
Sex Diagnosis  Clinical  ﬁndings  at  presentation
Fever  Abnormal
LFT
HSM LD  Non-speciﬁc
skin  lesion
MBH  NK
lymphocytosis
Others  Onset  (yrs
of age)
1  10  M  CAEBV  +  +  +  +  --  --  UK  --  8
2 10  M  CAEBV  +  +  +  +  --  --  --  Bowel  perforation,
cytopenia,  HLH
9
3 14  F  HV-like  T-LPD  +  --  --  --  --  --  UK  IgA  nephropathy  Infancy
4 16  F  HV-like  T-LPD  +  +  --  +  +  --  UK  --  UK
5* 10  M  CAEBV  with  MBH  +  +  --  +  --  +  UK  --  10
6 16  M  CAEBV  with  MBH  +  +  +  UK  --  +  UK  Eye  angioedema  14
7* 16  M  CAEBV  with  MBH  +  +  +  --  +  +  +  Bowel  perforation,
hypereosinophilia,
HLH
5
8 24  M  CAEBV  with  MBH  +  +  UK  UK  --  +  UK  HLH,  nausea,
vomiting
Since
childhood
9 22  M  CAEBV  +  +  +  +  --  --  +  Paroxysmal
dyskinesia,  severe
oral ulcer,
pneumonia,
thrombocyto-
penia,
HLH
20
10 27  F  CAEBV  +  +  +  --  --  --  UK  Headache,
pancytopenia,
lung  inﬁltration
3 months
ago
11 34  M  CAEBV  +  +  +  --  --  --  UK  Cytopenia,  HLH,
myalgia
33
12 43  M  CAEBV  +  +  +  +  --  --  UK  --  42
13 58  F  CAEBV  +  +  +  +  --  --  +  Myalgia,  blurred
vision
57
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Table  1  (Continued)
Patient TCR  Gene
rearrangement
EBV load  in  whole
blood/Serology
Treatment FU  (yrs) Outcome  Causes  of  death
1  Monoclonal  1143  copies/5  l HLH  2004  protocol 3  Died  Acute  hepatic  failure,  HLH,
hepatic encephalopathy
2 polyclonal  7.5  copies/5  l Allo  PBSCT 3 Alive
3 polyclonal  ND  CHOP  13  Died  Sepsis,  EBV+  T-cell  lymphoma
at larynx
4 polyclonal  ND  None  5  Alive
5* polyclonal  EA+,  VCA  IgM+,  35  copies/5  l ABVD  13  Alive
6 ND  7,000  copies/l/EA+,  VCA  IgM+  None  2.5  Alive
7* polyclonal  1,562  copies/5  l,  VCA  IgM/IgG
(--/+), EA+
EBNA+
HLH  2004  protocol  11  Died  HLH,  hematochezia
8 ND  ND  IMVP16  10  Died  ANKL
9  polyclonal  150  copies/5  l  CHOP,  ICE/DEXA  2  Died  HLH
10  polyclonal  6936  copies/5  l  UK  1.5/lost  to  FU  Alive
11  ND  17,230  copies/5  l
VCA IgG+,  -VCA  IgM-
EA+, EBNA+
None  1  Died  UK
12  ND  EA+,  VCA  IgG+,  EBNA+  None  0.5  Died  HLH
13  ND  326.40  copies/5  l  CVP  lost  to  FU  Alive
5*: Case 2, 7*: Case 1.
MBH,  mosquito-bite hypersensitivity; LFT, liver function test; LPD, lymphoproliferative disease; FU, follow up; ND, not done; ANKL, aggressive NK cell leukemia; HSM, hepatosplenomegaly;
LD, lymphadenopathy; PBSCT, peripheral blood stem cell transplantation; HV, hydroa vacciniforme; HLH, hemophagocytic lymphohistiocytosis; UK, unknown.
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suka M, et al. Pathogenic link between hydroa vacciniforme
and  Epstein-Barr virus-associated hematologic disorders. Arch6  
nd  polymorphic  lymphoproliferation  simulating  Hodgkin’s
ymphoma was  made.  The  patient  was  treated  with  ABVD
Adriamycin, Bleomycin,  Vinblastin,  and  Dacarbazine) for
ix cycles  with  complete  remission.  Currently  he  remains
ree of  disease  for  7  years  after  treatment.
. Discussion
he  clinical  course  of  CAEBV  patients  depends  on  the  bal-
nce between  EBV-related  factors  and  host  immune  function
nd can  be  smoldering,  progressive,  or  aggressive.  Some
atients develop  EBV+  T/NK  cell  lymphoma/leukemia.4,17
rom  1998  to  2014,  13  patients  aged  10--58  years  (median
ge 22  years,  nine  males  and  four  females)  were  diag-
osed with  CAEBV  disease  at  Samsung  Medical  Center,
orea (Table  1).  The  common  clinical  ﬁndings  included
ever (13/13),  hepatosplenomegaly  (9/12),  lymphadeno-
athy (7/11),  NK  lymphocytosis  (3/4),  MBH  (4/13),  and
V-like LPD  (2/13).  Some  patients  presented  with  bowel
erforation, chorea,  or  brain  infarction.  In  the  median
ollow-up of  36  months,  seven  patients  (54%)  died  of  the
isease, two  patients  (15%)  had  persistent  disease,  and  two
atients (17%)  were  free  of  disease.  Two  patients  were  lost
o follow-up.  The  causes  of  death  were  hemophagocytic  syn-
rome and  organ  failure  in  four  patients,  EBV-positive  T  cell
ymphoma  in  one  patient,  and  aggressive  NK  cell  leukemia
n one  patient.  B-lineage  lymphoproliferation  mimicking
odgkin’s lymphoma  as  seen  in  case  2  is  rare  but  has  been
reviously reported.18
CAEBV  infection  is  almost  always  accompanied  by  vary-
ng degrees  of  lymphoproliferation.  The  clonality  of  EBV
nd EBV-infected  T-  or  NK-cells  varies  and  may  be  poly-
lonal, oligoclonal,  or  monoclonal.  As  the  disease  progresses
rom polyclonal  lymphoproliferation  to  monoclonal  disease,
istological atypia  increases.  Ohshima  et  al.  proposed  the
ategorization of  CAEBV  into  three  groups----polymorphous
nd polyclonal,  polymorphous  and  monoclonal,  or  monomor-
hic and  monoclonal-based  on  clonality  and  histological
hanges.19 In  the  series  reported  by  Ohshima  et  al.,  8/48
atients with  CAEBV  infection  were  polyclonal  for  TCR
ene rearrangement  and  the  inﬁltrated  cells  displayed
olymorphic histomorphology;  15  patients  showed  poly-
orphic morphology  and  biclonal  or  monoclonal  TCR  gene
earrangement; and  25  patients  showed  monomorphic  his-
omorphology and  monoclonal  TCR  gene  rearrangement.
atients with  the  monomorphic  and  monoclonal  type  of
AEBV infection  had  poorer  prognoses  than  those  with
olymorphic polyclonal  or  polymorphic  monoclonal  dis-
ase. The  survival  of  the  polymorphic/polyclonal  and
olymorphic/monoclonal  groups  did  not  differ  signiﬁcantly.
onomorphic/monoclonal  groups  of  CAEBV  by  Ohshima
t al.  may  correspond  to  systemic  T-cell  LPD  according  to
he 2008  WHO  classiﬁcation.20
In  summary,  CAEBV  is  a  rare  EBV-associated  LPD  of  pre-
ominantly T-cell  or  NK-cell  lineage  with  a  broad  spectrum
f clinical  presentation.  Recognition  of  the  disease  is  impor-
ant for  adequate  management  of  the  patient.  EBV  analysis
hrough real-time  PCR  of  a  blood  sample  or  EBV  in  situ
ybridization in  the  affected  tissue  is  important  to  avoid
verlooking these  patients  and  should  be  included  in  the
rincipal diagnostic  tests  for  febrile  children.
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